COSCIENS Biopharma Inc. (CSCI) — Cash Flow-to-Debt Ratio
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow-to-Debt Ratio of -0.22x as of June 2025, meaning its operating cash flow of $-4.45 Million could theoretically repay 0% of its total liabilities ($20.46 Million) in one year. See COSCIENS Biopharma Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
COSCIENS Biopharma Inc. Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for COSCIENS Biopharma Inc. across 29 annual periods. For the full cash flow conversion analysis, see COSCIENS Biopharma Inc. cash flow conversion.
Annual Cash Flow-to-Debt Ratio for COSCIENS Biopharma Inc. (1996–2024)
Year-by-year debt coverage analysis for COSCIENS Biopharma Inc.. Check COSCIENS Biopharma Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.66x | $-14.57 Million | $21.91 Million | ▲ +30.2% |
| 2023 | -0.95x | $-2.58 Million | $2.71 Million | ▼ -173.1% |
| 2022 | 1.30x | $5.23 Million | $4.01 Million | ▲ +23.7% |
| 2021 | 1.05x | $2.75 Million | $2.61 Million | ▲ +16.3% |
| 2020 | 0.91x | $3.49 Million | $3.85 Million | ▲ +409.3% |
| 2019 | 0.18x | $675.29K | $3.79 Million | ▲ +117.7% |
| 2018 | -1.01x | $-1.56 Million | $1.55 Million | ▼ -436.6% |
| 2017 | 0.30x | $1.25 Million | $4.19 Million | ▼ -75.6% |
| 2016 | 1.22x | $3.63 Million | $2.97 Million | ▲ +140.5% |
| 2015 | 0.51x | $2.87 Million | $5.64 Million | ▲ +33.3% |
| 2014 | 0.38x | $1.84 Million | $4.82 Million | ▲ +278.1% |
| 2013 | 0.10x | $460.21K | $4.56 Million | ▲ +433.6% |
| 2012 | -0.03x | $-117.82K | $3.89 Million | ▼ -113.7% |
| 2011 | 0.22x | $791.62K | $3.58 Million | ▲ +60.3% |
| 2010 | 0.14x | $479.50K | $3.47 Million | ▲ +159.0% |
| 2009 | -0.23x | $-925.47K | $3.96 Million | ▼ -10.3% |
| 2008 | -0.21x | $-909.41K | $4.29 Million | ▲ +40.8% |
| 2007 | -0.36x | $-1.10 Million | $3.06 Million | ▼ -484.3% |
| 2006 | 0.09x | $140.59K | $1.51 Million | ▲ +142.6% |
| 2005 | -0.22x | $-368.84K | $1.69 Million | ▼ -280.8% |
| 2004 | -0.06x | $-76.65K | $1.33 Million | ▼ -171.1% |
| 2003 | 0.08x | $54.42K | $673.27K | ▲ +215.4% |
| 2002 | -0.07x | $-57.75K | $824.69K | ▲ +85.5% |
| 2001 | -0.48x | $-457.45K | $948.90K | ▼ -70.5% |
| 2000 | -0.28x | $-506.44K | $1.79 Million | ▼ -106.6% |
| 1999 | -0.14x | $-207.14K | $1.51 Million | ▲ +91.2% |
| 1998 | -1.56x | $-1.62 Million | $1.04 Million | ▼ -28.5% |
| 1997 | -1.22x | $-3.14 Million | $2.59 Million | ▼ -578.5% |
| 1996 | -0.18x | $-1.39 Million | $7.73 Million | — |